Appetite Control Might not Be Improved after Weight Loss in Adolescents with Obesity, Despite Non-Persistent Metabolic Syndrome.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
18 Dec 2020
Historique:
received: 10 11 2020
revised: 16 12 2020
accepted: 17 12 2020
entrez: 23 12 2020
pubmed: 24 12 2020
medline: 4 9 2021
Statut: epublish

Résumé

The aim of this study was to evaluate the effect of a multidisciplinary weight loss intervention on energy intake and appetite sensations in adolescents with obesity, depending on the initial diagnosis or persistence of the metabolic syndrome. Ninety-two adolescents with obesity (12-15 years) followed a 16-week multidisciplinary weight loss intervention. Anthropometric and body composition characteristics, metabolic profile, ad libitum daily energy intake, and appetite sensations were assessed before and after the intervention. The presence of metabolic syndrome (MS) was determined at baseline (MS vs. non-MS) and after the program (persistent vs. non-persistent). While the intervention was effective in inducing weight loss (body weight T0: 87.1 ± 14.9 vs. T1: 81.2 ± 13.0 kg;

Identifiants

pubmed: 33353174
pii: nu12123885
doi: 10.3390/nu12123885
pmc: PMC7766326
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Appetite. 2016 Oct 1;105:129-33
pubmed: 27224220
BMC Public Health. 2019 Nov 6;19(1):1457
pubmed: 31694610
Eur J Pediatr. 2013 Feb;172(2):215-21
pubmed: 23097084
Appetite. 2020 Sep 1;152:104711
pubmed: 32283186
Physiol Behav. 2017 Mar 1;170:62-67
pubmed: 27993515
J Clin Res Pediatr Endocrinol. 2008;1(2):53-60
pubmed: 21318065
Int J Obes (Lond). 2017 Mar;41(3):471-474
pubmed: 28017966
J Adolesc Health. 2008 Feb;42(2):119-27
pubmed: 18207089
Metab Syndr Relat Disord. 2009 Dec;7(6):549-55
pubmed: 19900159
Diabetes. 2006 Nov;55(11):2986-92
pubmed: 17065334
Physiol Behav. 2020 Feb 1;214:112744
pubmed: 31765664
Eat Weight Disord. 2017 Jun;22(2):211-229
pubmed: 27542161
Qual Life Res. 2017 Dec;26(12):3279-3288
pubmed: 28762099
Physiol Behav. 2020 Sep 1;223:112996
pubmed: 32505785
Am J Clin Nutr. 1999 Jul;70(1):145S-8S
pubmed: 10419418
Acta Endocrinol (Buchar). 2020 Jan-Mar;16(1):37-42
pubmed: 32685036
Clin Endocrinol (Oxf). 2013 Jul;79(1):55-64
pubmed: 22809141
Eur J Appl Physiol. 2012 May;112(5):1797-805
pubmed: 21909986
Am J Physiol Regul Integr Comp Physiol. 2019 Apr 1;316(4):R376-R386
pubmed: 30789791
Obesity (Silver Spring). 2008 Jun;16(6):1318-23
pubmed: 18356834
Appetite. 2019 Mar 1;134:125-134
pubmed: 30576727
Int J Endocrinol. 2013;2013:541032
pubmed: 24285955
Appl Physiol Nutr Metab. 2020 Apr;45(4):437-445
pubmed: 31505120
Int J Obes Relat Metab Disord. 2000 Jan;24(1):38-48
pubmed: 10702749
BMC Public Health. 2006 Mar 08;6:59
pubmed: 16524482
J Sport Health Sci. 2019 Mar;8(2):170-176
pubmed: 30997263
J Physiol Pharmacol. 2007 Mar;58 Suppl 1:13-35
pubmed: 17443025

Auteurs

Valérie Julian (V)

Department of Sport Medicine and Functional Explorations, Clermont-Ferrand University Hospital, G. Montpied Hospital, 63000 Clermont-Ferrand, France.
UFR Medicine, Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Laurie Isacco (L)

EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Marwa Khammassi (M)

EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Alicia Fillon (A)

EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Maud Miguet (M)

EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Frederic Dutheil (F)

Departement de Médecine du travail, Clermont-Ferrand University Hospital, G. Montpied Hospital, 63000 Clermont-Ferrand, France.
CNRS, LaPSCo, Physiological and Psychosocial Stress, Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Daniel Courteix (D)

EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont Auvergne University, 63000 Clermont-Ferrand, France.

Marek Zak (M)

Collegium Medicum, Jan Kochanowski University, Zeromskiego 5, 25-369 Kielce, Poland.

Jacek Bicki (J)

Collegium Medicum, Jan Kochanowski University, Zeromskiego 5, 25-369 Kielce, Poland.

Stanisław Głuszek (S)

Collegium Medicum, Jan Kochanowski University, Zeromskiego 5, 25-369 Kielce, Poland.

Martine Duclos (M)

Department of Sport Medicine and Functional Explorations, Clermont-Ferrand University Hospital, G. Montpied Hospital, 63000 Clermont-Ferrand, France.
UFR Medicine, Clermont Auvergne University, 63000 Clermont-Ferrand, France.
INRA, UMR 1019, 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.

Yves Boirie (Y)

UFR Medicine, Clermont Auvergne University, 63000 Clermont-Ferrand, France.
INRA, UMR 1019, 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.
Department of Human Nutrition, Clermont-Ferrand University Hospital, G. Montpied Hospital, 63000 Clermont-Ferrand, France.

Bruno Pereira (B)

Clermont-Ferrand University Hospital, Biostatistics unit (DRCI), 63000 Clermont-Ferrand, France.

David Thivel (D)

EA 3533, Laboratory of the Metabolic Adaptations to Exercise under Physiological and Pathological Conditions (AME2P), Clermont Auvergne University, 63000 Clermont-Ferrand, France.
CRNH-Auvergne, 63000 Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH